ArticleJournal of experimental & clinical cancer research : CR2023

TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.

Teng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.